v3.25.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Series A
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Due from Shareholders
Total Onconetix Equity (Deficit)
Non- controlling Interest
Total
Balance at Dec. 31, 2023 $ 6 $ 49,429,031 $ (625,791) $ (56,786,194) $ 2,380,920 $ (5,602,028) $ 7,006,504 $ 1,404,476
Balance (in Shares) at Dec. 31, 2023 3,000 571,033                
Balance (in Shares) at Dec. 31, 2023       (12,934)            
Issuance of restricted common stock
Issuance of restricted common stock (in Shares)   78                
Stock-based compensation expense 23,865 23,865 28,785 52,650
Foreign currency translation adjustment (4,991,144) (4,991,144) (4,991,144)
Change in pension benefit obligation 154,678 154,678 154,678
Net loss (11,118,572) (11,118,572) (11,118,572)
Balance at Mar. 31, 2024 $ 6 49,452,896 $ (625,791) (67,904,766) (2,455,546) (21,533,201) 7,035,289 (14,497,912)
Balance (in Shares) at Mar. 31, 2024 3,000 571,111                
Balance (in Shares) at Mar. 31, 2024       (12,934)            
Balance at Dec. 31, 2024 $ 118 127,825,626 $ (625,791) (115,683,621) (2,723,397) (250,308) 8,542,627 $ 8,542,627
Balance (in Shares) at Dec. 31, 2024 11,767,443                
Balance (in Shares) at Dec. 31, 2024       (12,934)           12,934
Issuance of common stock in connection with the ELOC $ 250 4,776,059 250,308 5,026,617 $ 5,026,617
Issuance of common stock in connection with the ELOC (in Shares)   25,006,563                
Stock-based compensation expense 29,256 29,256 29,256
Redemption of Series C Preferred Stock (1,170,091) (1,170,091) (1,170,091)
Foreign currency translation adjustment 141,048 141,048 141,048
Change in pension benefit obligation (30,779) (30,779) (30,779)
Net loss (8,545,885) (8,545,885) (8,545,885)
Balance at Mar. 31, 2025 $ 368 $ 132,630,941 $ (625,791) $ (125,399,597) $ (2,613,128) $ 3,992,793 $ 3,992,793
Balance (in Shares) at Mar. 31, 2025 36,774,006                
Balance (in Shares) at Mar. 31, 2025       (12,934)           12,934